CLLS | Cellectis SA

Company profile

Industry: Biotechnology
Sector: Healthcare
Headquarters: France

Number of employees:: 122

About the Company

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.

Subsidiaries: Calyxt, Cellectis stem cells, Cellectis, Inc
Revenue: 44.89M

Address

8, rue de la Croix Jarry
Paris 75013
France

Key Persons / Board of Directors

CEO : André Choulika, PhD

Notes

Back to Calendar view

Share it with fellow traders:

or join discussions in FB below
( FB comments )

Jump to (Finance sites)

Research

Investor page

www.cellectis.com

If you are looking for News & events, Press Release, they are available on their Investors Relationssite.

Consensus
BUY 100
HOLD 0
SELL 0

Their Official Profiles

Peers / Similar stocks

Other stocks

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media

Recommended Books

Buy on Amazon

Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.